Nearly 90,000 bottles of children’s liquid pain medication recalled
Advertisement
Read this article for free:
or
Already have an account? Log in here »
To continue reading, please subscribe:
Monthly Digital Subscription
$1 per week for 24 weeks*
- Enjoy unlimited reading on winnipegfreepress.com
- Read the E-Edition, our digital replica newspaper
- Access News Break, our award-winning app
- Play interactive puzzles
*Billed as $4.00 plus GST every four weeks. After 24 weeks, price increases to the regular rate of $19.95 plus GST every four weeks. Offer available to new and qualified returning subscribers only. Cancel any time.
Monthly Digital Subscription
$4.99/week*
- Enjoy unlimited reading on winnipegfreepress.com
- Read the E-Edition, our digital replica newspaper
- Access News Break, our award-winning app
- Play interactive puzzles
*Billed as $19.95 plus GST every four weeks. Cancel any time.
To continue reading, please subscribe:
Add Free Press access to your Brandon Sun subscription for only an additional
$1 for the first 4 weeks*
*Your next subscription payment will increase by $1.00 and you will be charged $16.99 plus GST for four weeks. After four weeks, your payment will increase to $23.99 plus GST every four weeks.
Read unlimited articles for free today:
or
Already have an account? Log in here »
WASHINGTON (AP) — Nearly 90,000 bottles of a children’s pain reliever have been recalled due to reports of black specs and other contaminants, according to federal regulators.
The Food and Drug Administration posted an online notice about the recall of Taro Pharmaceuticals’ Children’s Ibuprofen Oral Suspension. The company’s website states that the product comes in a berry-flavored solution and is recommended for children ages 2 to 11.
The FDA notice states that the recall was launched earlier this month after customers reported “a gel-like mass and black particles in the product.” Agency regulators categorized the action as one in which the risk of serious injury or health consequences to consumers is “remote.”
The medication was manufactured in India by Strides Pharma Inc., which produces generic and over-the-counter medicines for firms in the U.S. and many other countries. Strides initiated the recall, according to the FDA notice.
Neither Strides nor Taro Pharmaceuticals immediately responded to requests for comment Friday morning.
___
The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Department of Science Education and the Robert Wood Johnson Foundation. The AP is solely responsible for all content.
